SAB Biotherapeutics, Inc. (SABS)
$3.62-4.23%Close
BUYRECOVERY · day 49
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $35M
- Avg volume
- 747.0K
- Beta
- 0.53
- P/E (TTM)
- 2.92
- Short % float
- 58.87%
- Days to cover
- 8.9
- SI change
- +6.5%
- 1W
- -3.98%
- 1M
- +3.13%
- 3M
- -7.18%
- YTD
- -3.98%
- vs SPY 1W
- -2.79%
- vs SPY 1M
- -0.19%
- vs SPY 3M
- -9.57%
- vs SPY YTD
- -15.73%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- OMCLSELLOmnicell, Inc.CRISISQ 6$34.66-2.59%
- PTCTSELLPTC Therapeutics, Inc.RECOVERYQ 19$71.06+1.78%
- DXRSELLDaxor CorporationBEARQ 13$9.77-2.30%
- ARTLSELLArtelo Biosciences, Inc.CRISISQ -16$0.69+0.00%
- RVTYBUYRevvity, Inc.BULLQ 10$123.00-1.40%
- CMNDBUYClearmind Medicine Inc.CRISISQ -23$1.68-3.45%
- SGRYSELLSurgery Partners, Inc.CRISISQ 7$13.95-3.93%
- ALHCSELLAlignment Healthcare, Inc.CRISISQ 3$13.43+2.05%
- HSICBUYHenry Schein, Inc.BULLQ 14$89.51+1.14%
- CARMSELLCarisma Therapeutics, Inc.CRISISQ -12$0.00
- EMPGBUYEmpro Group Inc. Ordinary sharesBULLQ 83$17.36+0.00%
- PTGXBUYProtagonist Therapeutics, Inc.BULLQ 33$154.72+0.26%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
